Vol. 34.Issue. 1. January - February 2022 | Clínica e Investigación en Arteriosclerosis (English Edition)

ISSN: 2529-9123

Clínica e Investigación en Arteriosclerosis is the official journal of the Spanish Society of Arteriosclerosis, the Latinoamerican Society of Arteriosclerosis and the Iberolatinoamerican Society of Arteriosclerosis. The journal is the leading Spanish written peer-review journal in the field of arteriosclerosis and its related risk factors. The aim of the journal is primarily the promotion of knowledge and continued medical education, with a special focus in the Spanish-speaking audience, through the publication of relevant research contributions, basic and clinical, in the field and the publication of review and update articles.

See more Open Access Option

Clínica e Investigación en Arteriosclerosis has received its first journal Impact Factor (JCR) in 2023. Instructions for authors - Submit an article

"Methodological Notes": a new and important section in Clínica e Investigación en Arteriosclerosis

Indexed in:

Web of Science, Index Medicus/MEDLINE, Scopus, IBECS, IME, MEDES

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

1.9

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

3.2

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.424

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.435

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Vol. 34. Issue 1.

Pages 1-56 (January - February 2022)

Original articles

Impact of renal function on the prognostic value of mineral metabolism in patients with chronic ischaemic heart disease patients with chronic ischaemic heart disease

Álvaro Aceña, Ana María Pello-Lázaro, Juan Martínez-Milla, Óscar González-Lorenzo, Nieves Tarín, Carmen Cristóbal, Luis M. Blanco-Colio, José Luis Martín-Ventura, ... José Tuñón

Clin Investig Arterioscler. 2022;34:1-9

Full text access

Open Article

Situation in 2020 of the requirements for the use of PCSK9 inhibitors in Spain: Results of a national survey

Carlos Guijarro, Fernando Civeira, José López-Miranda, Luis Masana, Juan Pedro-Botet, Xavier Pintó, Pedro Valdivielso, José María Mostaza

Clin Investig Arterioscler. 2022;34:10-8

Open access

Open Article

Application of the individualized objectives defined by the European 2019 lipid guidelines in patients with type 2 diabetes

David Martín Enguix, Abraham Hidalgo Rodríguez, María Sánchez Cambronero, Juan Carlos Aguirre Rodríguez

Clin Investig Arterioscler. 2022;34:19-26

Full text access

Open Article

DNA methylation pattern of hypertriglyceridemic subjects

Montse Guardiola, Daiana Ibarretxe, Núria Plana, Lluís Masana, Josep Ribalta

Clin Investig Arterioscler. 2022;34:27-32

Full text access

Open Article

Editorial

Why is it important to know DNA methylation patterns in people with hypertriglyceridaemia?

Dolores Corella

Clin Investig Arterioscler. 2022;34:33-5

Full text access

Open Article

Clinical recommendations

Diabetes mellitus and cardiovascular risk: an update of the recommendations of the Diabetes and Cardiovascular Disease Working Group of the Spanish Society of Diabetes (SED, 2021)

Francisco Arrieta, Juan Pedro-Botet, Pedro Iglesias, Juan Carlos Obaya, Laura Montanez, Gonzalo Fernando Maldonado, Antonio Becerra, Jorge Navarro, ... Manuel Aguilar

Clin Investig Arterioscler. 2022;34:36-55

Full text access

Open Article

Indexed in:

Follow us:

Subscribe:

Subscribe to our newsletter